Summary
66 / 100 · Bulios Score
What speaks for it
- It holds more cash than debt: $453.4M against $187.8M.
- The share price is below the Bulios Fair Price.
- Out of every 100 TWD of revenue, 8.7 TWD is left as net profit.
What to watch
- Revenue fell by 11% a year over the last 3 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapPrice against the Bulios Fair Price
P/E against the industry (Chemicals - Specialty)
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 11.0 TWD for 1 TWD of yearly profit.
Valuation in detailIs it growing?
It is shrinkingRevenue (TWD)
Diluted EPS (TWD)
Revenue fell by 1.6% a year over 5 years. Over the last 3 years it fell by 11% a year. Earnings per share fell by 17% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 TWD of revenue goes
- Cost of sales 74 TWD
- Research and development 3.8 TWD
- Sales and administration 14 TWD
- Taxes and other -0.1 TWD
- Net profit 8.7 TWD
Net profit, industry median (Chemicals - Specialty) 31 TWD
Out of every 100 TWD of revenue, 8.7 TWD is left as net profit.
Profitability in detailIs it financially healthy?
YesRepaying all its debt would take 2.1 years of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
Moderate, stretched- Yield
- 3.91%
- Paid out of profit
- 43%
You receive $1.10 per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detail